Retusin

CAS No. 1245-15-4

Retusin ( —— )

Catalog No. M29223 CAS No. 1245-15-4

Retusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 197 Get Quote
10MG 340 Get Quote
25MG 561 Get Quote
50MG 794 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Retusin
  • Note
    Research use only, not for human use.
  • Brief Description
    Retusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.
  • Description
    Retusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.(In Vitro):Retusin exhibits potent free-radical-scavenging capacities. Retusin inhibits both cellular melanin formation and antityrosinase activity in B16F10 melanocytes.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    ATPase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1245-15-4
  • Formula Weight
    358.3
  • Molecular Formula
    C19H18O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(O)c2c(c1)oc(-c1ccc(OC)c(OC)c1)c(OC)c2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NDI-091143

    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

  • Fenbufen

    Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class.

  • Oligomycin A

    Oligomycin A, created by Streptomyces, acts as a mitochondrial F0F1-ATPase inhibitor, with a Ki of 1 μM.